• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2633
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Perforation of Vessels (2135)
Date of Event 05/20/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Adverse events that may occur and / or require intervention include, but are not limited to: vascular trauma (i.E., dissection, rupture, perforation, tear, etc.).
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2019, a patient was treated with gore investigational devices from the arise tbe 14-02 clinical trial, in emergent compassionate use.As part of the procedure, right femoral access was obtained using a 26fr gore® dryseal flex sheath.When the procedure was completed, the sheath was removed.A large segment of vessel endothelium and plaque was disrupted.This was treated by means of endarterectomy and complex primary repair and reconstruction of the femoral artery.The patient tolerated the procedure and was discharged on post-operative day 5.
 
Event or Problem Description
The following information was reported to gore: on (b)(6), 2019, a patient was treated with gore investigational devices from the arise tbe 14-02 clinical trial, in emergent compassionate use.As part of the procedure, right femoral access was obtained using a 26fr gore® dryseal flex sheath.The sheath was prepped per ifu.The access vessel diameter was 9mm.When the procedure was completed, the sheath was removed.A large segment of vessel endothelium and plaque was disrupted, despite the sheath was periodically rotated during the procedure.This was treated by means of endarterectomy and complex primary repair and reconstruction of the femoral artery.The patient tolerated the procedure.No transfusion was required.The patient was discharged on post-operative day 5.
 
Additional Manufacturer Narrative
H.6.Results code 1: 213: a review of the manufacturing records for the device verified the lot met all pre-release specifications.H.6.Conclusion code 1: 22: "according to the gore® dryseal flex sheath instruction for use (ifu) adverse events that may occur and / or require intervention include, but are not limited to: vascular trauma (i.E., dissection, rupture, perforation, tear, etc.) additionally it states the dsf2633 sheath is intended to be used in vessels with an internal diameter of at least 9.8mm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0)
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9060603
Report Number3007284313-2019-00278
Device Sequence Number11199717
Product Code DYB
UDI-Device Identifier00733132630103
UDI-Public00733132630103
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K160254
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/13/2021
Device Catalogue NumberDSF2633
Device Lot Number19999986
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date09/15/2019
Supplement Report FDA Received Date10/14/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age85 YR
Patient Weight77
-
-